Mylan agrees to meet with angry Sen. Grassley on EpiPen probe

Fierce Pharma ------- Senate Judiciary Committee Chairman Sen. Chuck Grassley, R-Iowa, went after Mylan this week for not cooperating with his EpiPen investigation, threatening to subpoena the drugmaker to get the info he needs. Now, Mylan officials have offered to meet as the senator pushes to learn about a Medicaid drug misclassification that cost taxpayers north of $1 billion and which one of Grassley's senate colleagues is demanding Mylan repay. Mylan reached out to set up a meeting for next Wednesday, a staffer for the senator said via email. A spokesperson for Mylan wrote to FiercePharma: "We have met, and continue to meet, with many congressional offices, including Sen. Grassley's." To learn more click on the picture below to read the article.